Table 3.
Serological group | Cohort | Presence of rash | Presence of eschar | Headache | Myalgia | Arthralgia | Localized lymphadenopathy | Generalized lymphadenopathy | Hepatomegaly | Splenomegaly | Conjunctival injections |
---|---|---|---|---|---|---|---|---|---|---|---|
ST seropositives | 1 | 36% | 67% | 88% | 35% | 36% | 33% | 02% | 40% | 23% | 14% |
2 | 10% | 55% | 55% | 39% | 43% | 20% | 21% | 23% | 13% | 00% | |
3 | 33% | 57% | 39% | 33% | 22% | 15% | 14% | 16% | 10% | 06% | |
SFG seropositives | 2 | 87% | 04% | 58% | 68% | 67% | 21% | 00% | 09% | 09% | 16% |
3 | 97% | 01% | 37% | 53% | 71% | 12% | 00% | 06% | 00% | 06% |